![](https://www.americanbazaaronline.com/wp-content/uploads/2024/07/215-Capital.jpg)
215 Capital invests $8 million in Medicus Pharma Ltd.
SkinJect, a Medicus Pharma subsidiary, is developing a pioneering non-invasive treatment for basal cell skin cancer. 215 Capital, a leading investment firm focused on pharmaceuticals, healthcare, and life sciences, has made an $8 million investment in …